Eukaryotic translation initiation factor 4A1 (EIF4A1) is a component of the translation initiation complex, and a high expression level of EIF4A1 is positively associated with poor tumor differentiation, late T stage, lymph node metastasis, advanced TNM stage, and poor prognosis in patients with gastric cancer (Gao et al., 2020). This evidence concerns the gene EIF4A1 and neoplasm.